湘佳股份(002982.SZ):與橙心優選擬共同投設泰淼供應鏈
格隆匯5月27日丨湘佳股份(002982.SZ)公佈,公司與橙心優選(成都)科技發展有限公司(“橙心優選”)簽署了《關於湖南泰淼供應鏈有限公司之合資經營合同》,擬共同投資設立湖南泰淼供應鏈有限公司(“泰淼供應鏈”)(名稱最終以工商局核准為準)。
泰淼供應鏈註冊資金為5000萬元人民幣,其中,公司以自有資金認繳出資3500萬元,持股比例為70%;橙心優選認繳出資1500萬元,持股比例為30%。此次投資完成後,泰淼供應鏈將成為公司的控股子公司。
此次對外投資是公司基於未來整體發展戰略考慮,通過有效整合各方的優勢資源,從而拓展公司業務發展空間,加速公司的戰略佈局,對公司的長遠發展具有積極意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.